Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Cover Mode
About NeoGenomics, Inc. (NASDAQ: NEO)
NeoGenomics Laboratories is a specialized genetics laboratory providing the latest diagnostic testing technologies to the pathology and oncology Communities. Staffed with specially trained hematopathologists and cytogenetic professionals, NeoGenomics Laboratories offers testing in cancer genetics, flow cytometry, immunohistochemistry and molecular diagnostics through its network of regional laboratories.
- Douglas M. VanOort / CEO
- George Cardoza / CFO
- Steven C. Jones / EVP, Fin.
- Grant Carlson / VP, Business Development
- Robert Horel / VP, Sales amp Mktg.
- Jerome J. Dvonch / Director, Fin.
- Edwin F. Weidig III / Principal Acct. Officer, Director, Fin.
- Raymond R. Hipp /
Current Share Structure
- Market Cap: $904,899,737 - 05/18/2018
- Issue and Outstanding: 80,507,094 - 03/05/2018
Daily Technical Chart for (NASDAQ: NEO)
Stay tuned for daily updates and more on (NASDAQ: NEO)
More to come on (NASDAQ: NEO)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NEO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of NEO and does not buy, sell, or trade any shares of NEO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/